Senior insider sale
SPYRE THERAPEUTICS, INC. — senior position signals high conviction
$5.85M
80K shares
What this filing means
HENDERSON MICHAEL THOMAS plans to sell 80K shares of SPYRE THERAPEUTICS, INC. valued at approximately $5.85M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/8/2026ACC: 0001950047-26-004262
Director
Since Jun 2023
80K
Shares to sell
$5.85M
Approx. market value
80K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
4/28/2024
80KTotal acquired80K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/28/2024 | Restricted Stock Units N/A | 80K | — |
| Total | 80K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
80K
Market value
$5.85M
5/8/2026
Total
Units
80K
Value
$5.85M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/8/2026 | 80K | $5.85M | NASDAQ | Planned |
| Total | 80K | $5.85M | ||